How to reconstitute NAD+, and how often the studies gave it
Reviewed 19 sourcesPublished by PepVault
How to mix an NAD+ vial with bacteriostatic water, the units for 100, 500 and 1,000 mg vials, and how often the human studies of NAD+ actually gave it.

- Last reviewed
- Sources
- 19
- Questions
- 9
- Compounds
- 1
The short answer
Wipe the stopper, run bacteriostatic water slowly down the inside wall of the vial and swirl until clear. The water sets the strength: a 500 mg vial with 2 mL is 250 mg/mL, so 50 mg, as an example, is 20 units (0.2 mL) on a U-100 insulin syringe. Studies gave NAD+ once, or daily for 4 to 7 days, by IV drip; none tested a long-term schedule.
Evidence: NAD+ itself has one pharmacokinetic pilot, one small clinic review and two short randomized hospital trials, all by IV; the longer trials are of the oral precursors NMN and NR, and no study has tested NAD+ injections at home.

Is NAD+ a peptide?
No. A peptide is a chain of amino acids (pepvault.app/glossary/peptide), and NAD+ has none. Its full name, nicotinamide adenine dinucleotide, says what it is: two nucleotides, each a sugar with a phosphate, joined at the phosphates. One carries adenine, the other nicotinamide, a form of vitamin B3. Its formula is C21H27N7O14P2, a small molecule of 663.4 g/mol2.
NAD+ is a coenzyme, a helper molecule that enzymes need to work. Cells use it to carry electrons in the reactions that turn food into energy, and the sirtuin and PARP enzymes, which help repair DNA, use it up as they work. Levels fall with age in rodents and people, the reason the longevity crowd tops it up1.
For mixing, NAD+ behaves like a peptide vial: a freeze-dried powder you turn into a liquid you can measure. Its doses are counted in milligrams, not micrograms, so the vials are bigger: 100 to 1,000 mg.
NAD+ has no FDA-approved drug19 (its legal status: pepvault.app/peptides/nad/legal-status), and vials sold for research use (pepvault.app/glossary/research-use-only) are not checked before sale, so the milligrams on the label are the seller's figure. In 2026, Belgium's public health institute reported an injection pen sold as NAD+ that held NADP+, a related but different molecule3.

PepVault for iPhone
Keep your protocol in PepVault
PepVault records the vial you mixed: the strength on the label and the date you mixed it, and it counts the doses left as you log them. The app works out no units; those come from your own math or the calculator above.
7 days free on the yearly plan for new subscribers.
What do you need to mix NAD+?
What you need
- The NAD+ vial, with its milligrams on the label.
- Bacteriostatic water: sterile water with 0.9% benzyl alcohol, a preservative that lets a vial be entered more than once4 (pepvault.app/glossary/bacteriostatic-water).
- U-100 insulin syringes, where 100 units fill 1 mL (pepvault.app/glossary/u-100-syringe): one to add the water, and a new one for every dose.
- Alcohol swabs and a sharps container, a puncture-proof box for used needles.
How much bacteriostatic water goes in an NAD+ vial?
There is no single correct volume. The water never changes how much NAD+ is in the vial, only how concentrated it is, and with it how far you pull the plunger. One formula links the numbers, the same one PepVault's calculator runs: units = dose in mg × water in mL × 100 ÷ vial in mg. For a 500 mg vial with 2 mL and a 50 mg dose: 50 × 2 × 100 ÷ 500 = 20 units, which is 0.2 mL.
The doses below are 50 and 100 mg, the range PepVault's library lists from community use of NAD+ under the skin (pepvault.app/lab/dosage/nad). They are there so the math has real numbers, not as a dose for you. Units are read on a 1 mL U-100 syringe; a 0.5 mL syringe stops at 50 units.
| Vial | Water | Strength | 50 mg is | 100 mg is | 50 mg doses per vial |
|---|---|---|---|---|---|
| 100 mg | 1 mL | 100 mg/mL | 50 units | 100 units (a full 1 mL) | 2 |
| 100 mg | 2 mL | 50 mg/mL | 100 units (a full 1 mL) | More than one syringe | 2 |
| 500 mg | 2 mL | 250 mg/mL | 20 units | 40 units | 10 |
| 500 mg | 5 mL | 100 mg/mL | 50 units | 100 units (a full 1 mL) | 10 |
| 1,000 mg | 5 mL | 200 mg/mL | 25 units | 50 units | 20 |

A 100 mg vial is small for these doses: it holds two 50 mg doses whatever the water. The 500 and 1,000 mg vials put the same doses at 20 to 50 units, an easy draw. Each size has its own chart page: 100 mg (pepvault.app/tools/reconstitution-calculator/nad-100mg), 500 mg (pepvault.app/tools/reconstitution-calculator/nad-500mg) and 1,000 mg (pepvault.app/tools/reconstitution-calculator/nad-1000mg). The calculator below works out any other mix.
Try it
Work out your draw
The calculator the app uses. Put in your vial, your water and your dose, and it shows the units to draw on a U-100 syringe.
Your vial and dose
Example numbersDraw to
40unitson a U-100 syringe
Lands on a numbered mark
- Concentration
- 5 mg/mL5,000 mcg/mL
- Doses per vial
- 5
PepVault records the vial you mixed: the strength on the label and the date you mixed it, and it counts the doses left as you log them. The app works out no units; those come from your own math or the calculator above. Track your vials in PepVault
How do you mix NAD+, step by step?
- Wash your hands and lay out the vial, the water, a new syringe, swabs and the sharps container on a clean surface.
- Flip the plastic caps off both vials and wipe each rubber stopper with an alcohol swab.
- Draw your planned volume of bacteriostatic water into the syringe. If it takes more than one syringe, use a new one each time you go back into the bottle: a vial is always entered with a new needle and syringe18.
- Push the needle through the NAD+ stopper and aim the stream at the glass wall, not at the powder, so it does not foam6.
- Swirl the vial in small circles until the powder is gone. Do not shake it56.
- Hold it to the light. It should be clear, with no particles; if it is not, do not use it46.
- Write the date and the strength (for example "250 mg/mL") on the vial, and put it in the fridge.
Clinics that give NAD+ as a drip add one step: in one clinic's records, nurses dissolved 500 mg in bacteriostatic water, then diluted it in a 500 mL bag of saline, which lets the drip run slowly9.
How long does mixed NAD+ keep?
We found no published study of how long NAD+ stays stable in bacteriostatic water. The water's own label says not to store a mixed drug unless the drug's maker says you can4, and a research vial comes with no such instructions. The reference points that do exist:
- Any opened multi-dose vial: the CDC's rule for clinics is to date it and discard it within 28 days, unless the maker states another date7. That is an infection-control limit, not a measure of NAD+'s stability.
- The bacteriostatic water bottle: one approved label says to discard it 28 days after first use5.
- In the trials: each day's drip was mixed for that day's infusion910.
Commonly reported: users keep a mixed vial in the fridge and size it to finish within a few weeks, a habit, not a measured shelf life. The expiry tool (pepvault.app/tools/reconstituted-peptide-expiry) counts the days from the date you mixed it.
How often did the human studies give NAD+?
Few studies have given NAD+ itself to people, and none for longer than a week. Every regimen we found:
| Study | Who | How it was given | How often |
|---|---|---|---|
| Grant 20198 | 8 healthy men, 30-55 (3 more on saline) | 750 mg IV drip over 6 hours, about 2 mg a minute | Once |
| Reyna 20269 | 6 clients of a US clinic chain that employed the authors and funded the study (8 more got NR) | 500 mg IV drip in 500 mL saline | 4 days in a row |
| Yu 202610 | 180 adults with heart failure (half on placebo) | 10 mg IV drip in 100 mL | Once a day for 7 days |
| Yu 202611 | 120 adults after a heart attack, NAD+ or placebo | 10 mg IV | Once a day for 7 days |
| NCT0691932812 | Healthy adults 40-65, with ChromaDex, which sells NR; listed as recruiting, last updated April 2025 | 100 mg in 2 mL bacteriostatic water, under the skin, into muscle or IV | No results posted |

The first study is the one that shows where infused NAD+ goes. At about 2 mg a minute, blood NAD+ did not rise at all for the first 2 hours: the body cleared it as fast as it came in. By the end of the 6 hours it was roughly 400% above its starting level, and no adverse events were recorded8.

The two heart trials are the only randomized trials of NAD+ itself with a health outcome that we found, at a dose far below the wellness drips. The share of blood the heart pumps out per beat (LVEF) was 45.4% against 42.4% on placebo in heart failure10, and 56.3% against 53.4% after a heart attack11. A 2026 systematic review found 33 human intervention studies in the field, and none tested IV or intramuscular NAD+ itself on ageing or wellness outcomes13.
No study has tested a schedule of NAD+ injections at home over weeks or months.
What about NMN and NR, the pills?
NMN (pepvault.app/peptides/nmn) and NR, nicotinamide riboside (pepvault.app/peptides/nicotinamide-riboside), are precursors: building blocks the body turns into NAD+. They are swallowed, not mixed, and most of the field's human evidence is theirs, from trials that ran daily for weeks:
| Precursor trial | Who | Daily amount | How long | What changed |
|---|---|---|---|---|
| Martens 2018, NR14 | 30 healthy adults, 55-79 | 500 mg twice a day | 6 weeks | NAD+ in blood cells rose about 60%; well tolerated |
| Yoshino 2021, NMN15 | 25 women with prediabetes | 250 mg once a day | 10 weeks | Muscle insulin sensitivity rose |
| Yi 2023, NMN16 | 80 healthy middle-aged adults | 300, 600 or 900 mg once a day | 60 days | Blood NAD+ rose in every group, most at 600-900 mg |
| Pencina 2023, NMN17 | 32 adults, 55-80, overweight | 1,000 mg once or twice a day | 14 days | Blood NAD+ rose |
The comparison page (pepvault.app/peptides/compare/nad-vs-nmn) sets the injected and the oral routes side by side.
Why does NAD+ cause flushing, nausea or chest pressure?
These track how fast NAD+ goes in. In the clinic review, all six people on the NAD+ drip had stomach cramps, nausea, a faster heart rate or chest pressure during the infusion, and every symptom stopped when the infusion ended. They slowed their drips, so a 500 mg bag took 97 minutes on average, against 37 minutes for the same amount of NR9. The 6-hour drip at about 2 mg a minute recorded no adverse events on clinical observation8.
Commonly reported: a warm flush, queasiness or a tight chest when NAD+ goes in fast, which eases within minutes of slowing down or stopping; under the skin, a short sting at the site, which users manage by pushing the plunger slowly over a minute or two.
When to get help Chest pain that does not ease within a few minutes of stopping, or trouble breathing, is a reason to get medical help straight away.
How often do people run NAD+ on their own?
Commonly reported: under the skin, 50 to 100 mg daily or every other day, in the morning since it can feel energising, in blocks of 2 to 6 weeks a few times a year or as a low dose all along. Clinics run drips of 250 to 1,000 mg, often as several days in a row.
None of those patterns comes from a trial: the closest are the 4- and 7-day courses above, and the trial under the skin has not reported yet12. A schedule is set with a clinician.
Daily or every other day, PepVault reminds you on the days your schedule sets and logs each dose, so a block of weeks is easy to look back on. Set reminders in PepVault
Next: the general method in How to reconstitute peptides, then the NAD+ entry (pepvault.app/peptides/nad) with its side effects (pepvault.app/peptides/nad/side-effects) and its studies (pepvault.app/research/nad-yu-2026). NAD+ sits among the supplements and medicines on the longevity hub (pepvault.app/longevity).
Sources
- Covarrubias AJ et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021. PubMed 33353981
- National Center for Biotechnology Information. PubChem Compound Summary for CID 5892, NAD+ (nicotinamide adenine dinucleotide). pubchem.ncbi.nlm.nih.gov
- Vanhee C et al. A case of mistaken identity: NADP+ substitution in an illicit NAD+ injection pen marketed for aesthetic enhancement and wellness. Drug Test Anal. 2026. PubMed 42977552
- Hospira. Bacteriostatic Water for Injection, USP: prescribing information. DailyMed. dailymed.nlm.nih.gov
- Theratechnologies. EGRIFTA WR (tesamorelin) for injection: prescribing information and Instructions for Use. Revised 03/2025. DailyMed. dailymed.nlm.nih.gov
- Ferring Pharmaceuticals. ZOMACTON (somatropin) for injection: prescribing information and Instructions for Use. DailyMed. dailymed.nlm.nih.gov
- Centers for Disease Control and Prevention. Preventing unsafe injection practices. Injection Safety. 2024. cdc.gov
- Grant R et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019. PubMed 31572171
- Reyna K et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026. PubMed 41704678
- Yu X et al. Effect of nicotinamide adenine dinucleotide on heart failure caused by ischemic cardiomyopathy: a randomized, placebo-controlled trial. Am J Cardiovasc Drugs. 2026. PubMed 40954388
- Yu X et al. Effect of intravenous nicotinamide adenine dinucleotide on left ventricular function after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: a randomized controlled trial. Am J Cardiovasc Drugs. 2026. PubMed 42961639
- ClinicalTrials.gov. NCT06919328: Absorption and tolerability of injectable administration of Niagen+ (nicotinamide riboside chloride) as compared to NAD+. Nutraceuticals Research Institute. clinicaltrials.gov
- Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026. PubMed 41655607
- Martens CR et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018. PubMed 29599478
- Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. PubMed 33888596
- Yi L et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023. PubMed 36482258
- Pencina KM et al. MIB-626, an oral formulation of a microcrystalline unique polymorph of β-nicotinamide mononucleotide, increases circulating nicotinamide adenine dinucleotide and its metabolome in middle-aged and older adults. J Gerontol A Biol Sci Med Sci. 2023. PubMed 35182418
- Centers for Disease Control and Prevention. Considerations for blood glucose monitoring and insulin administration. Injection Safety. 2024. cdc.gov
- U.S. Food and Drug Administration. Drugs@FDA: no approved drug product lists NAD+ (nadide) as an active ingredient. Searched November 20, 2026. accessdata.fda.gov
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.